Sarcoma PDX Models

Patient-derived xenograft (PDX) models provide a predictive preclinical model for the evaluation of an agents efficacy prior to entering the clinic. The Crown Bioscience collection contains many sarcoma PDX models of both North American and Asian decent for a true representation of the variability found in the patient population. More

PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience’s HuPrime® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.
MODEL NUMBERCANCER SUBTYPE # per page
SA0271Spindle cell carcinomaCLICK TO VIEW
SA0319Spindle cell carcinomaCLICK TO VIEW
SA0639rhabdomyosarcomaCLICK TO VIEW
SA0666Spindle cell carcinomaCLICK TO VIEW
SA10132SarcomaCLICK TO VIEW
SA10139clear cell sarcomaCLICK TO VIEW
SA10145SarcomaCLICK TO VIEW
SA10146NACLICK TO VIEW
SA10151NACLICK TO VIEW
SA10153SarcomaCLICK TO VIEW
SA10154SarcomaCLICK TO VIEW
SA10157LEIOMYOSARCOMACLICK TO VIEW
SA10159synovial sarcomaCLICK TO VIEW
SA10160LEIOMYOSARCOMACLICK TO VIEW
SA10162synovial sarcomaCLICK TO VIEW
SA10164SarcomaCLICK TO VIEW
SA10166SarcomaCLICK TO VIEW
SA10171Soft Tissue SarcomaCLICK TO VIEW
SA10174RHABDOMYOSARCOMACLICK TO VIEW
SA10175SarcomaCLICK TO VIEW

Create Account to View All Model Data

Already Registered? Login